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Background: The 6-min walking distance (6MWD) test is a useful tool for assessing patients
with chronic obstructive pulmonary disease (COPD), but little is known about the changes
in oxygen saturation that occur during the test.
Objective: To predict the oximetry proﬁle during daily living activities by the time to
desaturation in the 6MWD test in COPD-affected patients.
Patients and methods: We studied 67 COPD patients with moderate hypoxemia
performing a 6MWD test and a 24-hour ambulatory pulse oximetry (24-hr PO). We
determined the time to desaturation (SatO2p90%) in the 6MWD test, in the daytime,
nighttime and 24-hr PO. We then estimated the time to desaturation that better predicts
desaturation in diurnal, nocturnal and 24-hour oximetries using the ROC type II analysis.
Results: The patients who desaturated after 3030min have a 100% probability not to
desaturate during diurnal, nocturnal and 24-hr PO. Those patients who desaturated during
the ﬁrst minute of the 6MWD test have a 74% probability to desaturate in these oximetries.
Conclusions: The time to desaturation in the 6MWD test can discriminate early
desaturators who desaturate during their daily living activities and late desaturatorsElsevier Ltd. All rights reserved.
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Time to desaturation in 6MWD test predicts 24-hour oximetry 1027who do not desaturate. Ambulatory oximetry would thus only be necessary in patients with
a time to desaturation that ranges between 1 and 303000.
& 2008 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is a prevalent
disease with a high morbidity and mortality.1,2 In order to
adequately evaluate the disease, pulmonary function tests
and the 6-min walking distance test (6MWD) are necessary.
The 6MWD test has become a common tool for assessing the
disease.3 Decker et al.4 were the ﬁrst to perform oximetric
monitorization with old and uncomfortable devices that
evaluated the changes in haemoglobin desaturation ob-
served during the test. Small and comfortable portable
pulse oximetry devices which can monitor data up to 24 h
(24-hour pulse oximetry, 24-hr PO) are now available. Most
of the published work in this ﬁeld has been performed during
the nighttime period,5–7 whereas few studies have been
conducted during the daytime when patients perform most
of their daily living activities.8,9 When the desaturation time
is equal to or greater than 30% of the total sleeping time, it
is considered to be signiﬁcant.6,10
Even though a 24-hr PO evaluation provides useful clinical
information, it is somewhat cumbersome for the patients
because they are required to collaborate while performing
their activities of daily living.
The 6MWD test is simple and well tolerated. Moreover, it
does not need complex devices, and it has been shown to
correlate well with peak VO2
11 and health-related quality of
life.12 Pulse oximetry during the test can provide useful
information regarding the time when the oxygen saturation
(SatO2) falls under 90% in those patients at risk to
desaturate.
Our hypothesis is that the time it takes for a patient to
desaturate under 90% in a 6MWD test can predict the amount
of time it takes this patient to spend SatO2 under 90% during
his daily living activities, including the daytime period. We
believe that if this hypothesis is conﬁrmed by experimental
data, a 6MWD test could substitute a 24-hr PO to evaluate
COPD patients at risk to develop hypoxemia.Methods
Patients
We prospectively included patients who attended the
Candelaria University Hospital and the Canarian University
Hospital from February 2002 to December 2005 who fullﬁlled
the following criteria: smoker or former smoker with a COPD
diagnosis according to the ATS criteria,13 i.e. FEV1/
FVCo70% with a resting PaO2 that ranges between 60 and
70mmHg. Patients were excluded if they had a history of
asthma, bronchiectasis, pulmonary hypertension, obstruc-
tive sleep apnea, central apnea, cardiovascular or renal
disease that may predispose to the development of
hypoxemia. All the patients were in a stable condition, free
of exacerbation for at least 2 months. Sixty-one patients(51 patients with 50/500, 10 patients with 50/250) were
administered tiotropium and a combination of salmeterol/
ﬂuticasone, and 6 patients were administered tiotropium
only. All the patients had to be able to perform
a 6MWD test and a 24-hr PO. They were all informed about
the study and they all signed a written informed consent
that had been approved by the Ethical Committee of both
hospitals.
Patients were evaluated within 4 weeks of enrollment.
PaO2 was measured while the patients were at rest,
breathing room air and in the sitting position. The arterial
blood gas sample was obtained from the radial artery and
analysed by a blood gas analysis machine (Gem Premier
3000-mod 5700, Gem Systems Instrumentation Laboratory,
Lexington, MA, USA). Pulmonary function tests, including
spirometry, lung volumes and CO diffusion were measured
according to ATS guidelines14 by a pulmonary function labo-
ratory (Master Lab Jaegger, GMBH, Wuerzburg, Germany).
Because there is no equation to assess the normal
spirometric inspiratory capacity (IC) values, the ratio
between IC and total lung capacity (IC/TLC) was used as a
measure of resting hyperinﬂation. The best of two 6MWD
tests, separated one from the other by at least 30min, was
selected following ATS recommendations.15 The body mass
index (BMI) was calculated in kg/m2. The BODE index (BMI,
Obstruction, Dyspnea, Effort) was calculated following Celli
et al.16
Oximetry was performed with a portable pulse oximeter
(pulsio3ia; Minolta; Japan) with computer software to
record ambulatory oximetry data (AOM). Each parameter
(O2Sat and pulse rate) was recorded every 2 s. The digital
probe was attached to the left hand for right-handed
patients and to the right hand for left-handed ones. The
probe was attached to the ﬁnger and secured to the wrist.
All data obtained during the AOM monitoring period were
downloaded from the oximeter to a computer for ﬁnal
analysis. A calibration check was run following the manu-
facturer instruction and checked before and after use by
the patients. The time to desaturation was validated in a
group of 15 patients and was the same for two consecutive
tests.
Pulse oximetry proﬁle
Fletcher et al.5 considered a desaturation time of more than
30% under 90% O2Sat to deﬁne a desaturator in the nighttime
oximetry. We used that same deﬁnition of desaturation time
for 24 h and daytime periods. Because of lack of consensus in
the literature, we also evaluated 3 different cut-off points
to deﬁne a ‘‘desaturator’’, viz., we considered 20%, 30% and
40% or more spent under a O2Sato90%. Daytime oximetry
was deﬁned as the time when the patient was awake, and
nighttime oximetry as the time when the patient was
sleeping, including the naptime. The sleeping time analysed
was the one mentioned by the patient on the following
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without knowing the 6MWD test results.
Early and late desaturators during the 6MWD
‘‘Early’’ and ‘‘late’’ desaturator thresholds were deﬁned.
The early desaturator value was deﬁned as the time a
patient desaturates in the walking test that highly predicts
the time spento90% O2Sat in the 24-hr PO. We selected the
time to desaturation as the one with the highest sensitivity
in order to select all the patients who desaturate during the
24-hr PO. The late desaturator value was deﬁned as the time
a patient desaturates in the walking test that highly predicts
the possibility not to desaturate in the 24-hr PO. We then
selected again the time to desaturation with the highest
sensitivity and speciﬁcity in order to avoid including in this
group any patient who may desaturate during the 24-hr PO,
as was previously explained. We performed each calculation
for the 3 different cut-off values of time spent o90% in the
24-hr PO (20%, 30% and 40%).0.0
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Figure 1 Receiver-operating characteristic curve for time to
desaturation in 6MWD test with pulsioximeter as predictor of
30% or more of time with SatO2o90% in diurnal oximetry.Data processing
Because of the variable skewness, their median and range
values were used. Range was used instead of percentiles in
order to obtain more information about the variable
extreme values. Spearman’s coefﬁcients were used to assess
the correlation between the time to desaturation in the
6MWD tests and the time of desaturation in the daytime,
nighttime and 24-hr PO. Taking into consideration the
desaturators and non-desaturators in each period of the
ambulatory oximetry evaluation (daytime, nighttime and
24-hour period), a ROC type II analysis was applied to
evaluate the sensitivity, speciﬁcity, positive and negative
predictive values of the time to desaturation to predict the
pulse oximetry desaturation. All the calculations were
performed by means of the statistical software package
SPSS 12.0TM Inc.& Chicago, IL, USA.Results
The cut-off point of 30% of time with SatO2 o90% included
20 patients (30%) in the 24-hour period, 17 (25%) in the
daytime and 30 (45%) in the nighttime periods. The
correlation between the time to desaturation in the 6MWD
tests and more than 30% of time desaturating o90% for
the different cut-off values were: 0.576 (po0.001) for0.0
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Figure 2 Receiver-operating characteristic curve for time to
desaturation in 6MWD test with pulsioximeter as predictor of
30% or more of time with SatO2o90% in nocturnal oximetry.
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Figure 3 Receiver-operating characteristic curve for time to
desaturation in 6MWD test with pulsioximeter as predictor of
30% or more of time with SatO2o90% in 24-hour oximetry.
Table 1 Patients’ sample characteristics and results of
6MWD tests with pulse oximeter and 24-hour oximetry.
Characteristic/parameter/measure Value
General characteristics
Gender (M/F) 61/6
Age (years old) 65 (50–79)
FEV1 predicted (%) 37 (16–64)
FVC (liters) 64 (28–129)
PO2 (mmHg) 66 (60–70)
PCO2 (mmHg) 45 (32–57)
TLCO (mmHg) 64 (21–105)
BODE (points) 4 (1–8)
IC/TLC (%) 28 (25–33)
6MWD test with pulse oximeter results
Distance walked (m) 417 (125–625)
Time to SatO2o90% (min) 101200 (000600503000)
Distance to SatO2o90% (m) 75 (15–384)
Start saturation (%) 93 (91–96)
Ending saturation (%) 84 (70–88)
24-hour oximetry results
SatO2o90% 24-h time (min) 2420 (50–10800)
SatO2o90% 24-h time (%) 17 (0.3–75)
0 0 0
Time to desaturation in 6MWD test predicts 24-hour oximetry 1029daytime, 0.464 (po0.001) for nighttime and 0.417
(po0.001) for the 24-hour period.
Figure 1 shows the ROC type II curve for the values of the
time to desaturation in the 6MWD tests that predicts a
desaturation time 430% for the daytime period. Figure 2
shows the ROC type II curve for the values of the time to
desaturation in the 6MWD tests that predicts a desaturation
time 430% for the nighttime period.
Figure 3 shows the ROC type II curve for the values of the
time to desaturation in the 6MWD tests that predicts a
desaturation time 430% for the 24-hour period.
An early desaturator was deﬁned as one who desaturated
within 1min of the 6MWD test, because this was the amount
of time with the best sensitivity to predict ambulatory
oximetry desaturation. By contrast, a late desaturator was
deﬁned as one who desaturated 303000 (or more) after
beginning the 6MWD test because this was the amount of
time with the best sensitivity to predict the absence of
desaturation during ambulatory oximetry.SatO2o90% diurnal time (min) 98 (2 –590 )
SatO2o90% diurnal Holter time (%) 15 (0.2–82)
SatO2o90% nocturnal time (min) 980 (30–6180)
SatO2o90% nocturnal time (%) 23 (0.7–92)
Frequency, percentage or median (range).Discussion
We analysed the desaturation proﬁle of COPD patients
with a PaO2 between 60 and 70mmHg during 2 differenttests: the 6MWD test on one hand, and the 24-hr PO on the
other. The main and most important ﬁnding of our study lie
in the fact that many patients who desaturated within the
ﬁrst minute of the 6MWD test also desaturated in the 24-hr
PO, and those that only desaturated after 303000 of the 6MWD
test did not desaturate in the 24-hr PO.
Previous research described functional parameters that
predict desaturations during the 6MWD test, such as Hadeli
et al.17 who studied 8000 patients. They concluded that a
diffusion capacity for CO (DLCO)o62% of the reference
value was a good predictor of desaturation during a
submaximal exercise. Other researchers studied the pre-
dictive parameters of nocturnal desaturation. Plywaczewski
et al., for example, studied 82 patients with COPD who
received long-term oxygen therapy (LTOT). They observed
that an increased basal daytime PaCO2 was a good predictor
of nocturnal desaturation.18 Our objective was not to
analyse basal parameters as CO diffusion or PCO2 with
desaturation during exercise or nocturnal time. As Table 1
indicates, the mean basal PaO2 media was 66mmHg, the
mean PaCO2 45mmHg, and the mean DLCO was 64% of
predicted (Table 2).
Few studies compared desaturation proﬁles while the
patients perform an exercise test and during their nighttime
period. Mulloy et al. did not ﬁnd any relationship between
the treadmill exercise desaturation and sleep desaturation
in 25 COPD patients,19 while Fletcher et al.’s ﬁndings
showed that exercise desaturation was not predictive of
nocturnal desaturation.20 The aim of our research was not
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Table 2 Cut-off points of time to desaturation in the 6MWD test to predict a O2Sato90% time greater than 20%, 30% and 40% in the diurnal, nocturnal and 24-hour oximetry.
Oximetry reference Cut-off point for time to desaturation in 6MWD test with pulsioximeter and their prognostic
characteristics
No early nor later
desaturators remained
with indication to
ambulatory oximetry
(%)
Early desaturator Later desaturatory
Desaturation
threshold
(% time with
O2Sato90%)
Oximetry day
period type
Desaturators
over
threshold
(%)
Time to fall
in O2Sat
o90% (min)
Desaturators
according
ambulatory
oximetry
(%)z
No
desaturators
according
ambulatory
oximetry
(%)y
Time to fall
in O2Sat
o90% (min)
No
desaturators
according
ambulatory
oximetry
(%)z
Desaturators
according
ambulatory
oximetry
(%)J
20 Diurnal 42 1:00 72 13 3:30 100 0 51
Nocturnal 52 1:00 72 16 3:30 100 0 51
24 h 43 1:00 67 16 3:30 100 0 52
30 Diurnal 25 1:00 67 18 3:30 100 0 51
Nocturnal 48 1:00 74 14 3:30 100 0 52
24 h 33 1:00 61 16 3:30 100 0 52
40 Diurnal 19 1:00 50 19 3:30 100 0 52
Nocturnal 38 1:00 51 17 3:30 100 0 52
24 h 18 1:00 50 20 3:30 100 0 52
Early desaturator: patient with a O2Sato90% time over threshold in respective oximetry and then candidate for LTOT administration.
yLater desaturator: patient with a O2Sato90% time under threshold in respective oximetry and then candidate for not LTOT administration.
zCut-off time to desaturation in 6MWD test positive predictive value relative to reference oximetry over threshold as gold standard.
yCut-off time to desaturation in 6MWD test false positive proportion relative to reference oximetry over threshold as gold standard.
zCut-off time to desaturation in 6MWD test positive predictive value relative to reference oximetry under threshold as gold standard.
JCut-off time to desaturation in 6MWD test false negative proportion relative to reference oximetry under threshold as gold standard. I.G
arcı´a-Talavera
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Time to desaturation in 6MWD test predicts 24-hour oximetry 1031only to analyse parameters that could predict nocturnal
desaturation, but also to ﬁnd parameters that could predict
ambulatory oximetry.
In a prospective study using ambulatory oximetry, Fussell
et al. did not ﬁnd any relationship between desaturations
during the 6MWD test and those occurring during daily living
activities.21 They studied ambulatory oximetry during 24 h
and desaturation during a 6MWD test with the aim of
assessing the need for LTOT. They analysed 20 patients only
and the lowest oxygen saturation, but they did not measure
the time to desaturation in a 6MWD test. Their conclusion
that ambulatory oximetry monitoring is better to prescribe
oxygen therapy is quite convincing, but we did ﬁnd a way to
predict desaturation during ambulatory oximetry by using
the time to desaturation during the 6MWD test.
We were particularly interested in the group of COPD
patients (PaO2 between 60 and 70mmHg) who do not
formally qualify for oxygen therapy but who are at high risk
of developing oxygen desaturations during their activities of
daily living. We therefore designed this study to describe
these patients’ 24-hr-PO proﬁle and then determine
whether their 6MWD test pulse oximetry desaturation proﬁle
could predict what happened during the 24-hour period.
Twenty ﬁve percent of the patients were found to be
daytime desaturators, 45% nocturnal desaturators and 30%
24-hour desaturators. Our ﬁndings agree with previous
research and reﬂect a predominance of nocturnal desatura-
tors in COPD patients. We chose 1min as the time to
desaturation that best predicted daytime, nocturnal and 24-
hr-PO desaturations as shown in Figures 1–3. We also chose
303000 as the time to desaturate in the 6MWD test that better
predicts the event of no desaturation during the daytime,
nighttime and 24-hr PO. Our results also indicate that there
is a relationship between the time to desaturation during a
submaximal effort and desaturation during daily living
activities in these patients, although we acknowledge that
these are two different efforts. During the 6MWD test, many
COPD patients may desaturate, but during their daily
activities they may not desaturate because they do not
usually perform a submaximal effort. We did ﬁnd a relation,
though, between the desaturation observed during the
6MWD test and that observed during the sleeping time,
but we do not know how to explain these ﬁndings from a
physiological standpoint. Some patients’ desaturate during
diurnal activity, others during their sleeping time, and some
others do so in both periods. However, our results suggest
that there is a relationship between the desaturation
observed during the 6MWD test and those recorded during
the daytime and nighttime periods.
An important implication of our ﬁndings is that they could
affect the decision to administer LTOT in patients with
COPD. Resting oxygen saturation and lowest exercise
saturation during a 6MWD test is the standard method of
determining LTOT requirement.13 We agree with Fussell
et al.21 and Pilling and Cutaia22 that it is with a 24 h
ambulatory oximetry that the real life oxygen saturation is
best reﬂected. Furthermore, Turner et al. and Poulain et al.
have demonstrated that the 6MWD test is a very sensitive
test to detect desaturations in patients with COPD.23,24
Another recent study has also demonstrated that the 6MWD
test is useful for adjusting LTOT.25 We thus believe that our
ﬁndings support the idea that the 6MWD test in patients withCOPD can also be used for other purposes, as suggested by
Pinto-Plata et al.26 These patients’ saturation proﬁle during
the test can be used to predict their desaturation proﬁle
while performing their daily living activities.
A possible limitation of our study is that the 24-hr PO
monitorization was performed without determining the
patients’ concommitant physical activity by means of a
questionnaire or an accelerometer, as recommended by
Pitta et al.27 and Cohen et al.28 Another limitation is that we
do not know the importance these 24-hour oximetry
desaturations have over these patients’ overall morbidity
and mortality. Follow-up studies are required to ﬁnd an
answer to this question.
In conclusion, the time to desaturation o90%SatO2 less
than 1min in the 6MWD test in COPD patients with PO2
between 60 and 70mmHg predicts a high possibility of
desaturation during the 24-hr PO. Moreover, a time to
desaturation greater than 303000 predicts a high possibility
not to desaturate in the 24-hr-PO period. The ambulatory
oximetry would thus be necessary only in patients with a
time to desaturation that ranges between 1 and 303000 min.
This information can be used to better diagnose and treat
this desaturation, the importance of which is still unknown.
Further studies are required to apply these results in the
administration of oxygen therapy during efforts in early
desaturators.
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